Jennifer L. Schmachtenberg

A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder

A. Janowsky, Z. Xi, A. Newman, 2022, Neuropsychopharmacology.

Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and Transporters

A. Janowsky, A. Eshleman, T. Swanson, 2020, The Journal of Pharmacology and Experimental Therapeutics.

A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder

A. Janowsky, Z. Xi, A. Newman, 2022, Neuropsychopharmacology.

New dual 5-HT1A and 5-HT7 receptor ligands derived from SYA16263.

A. Janowsky, A. Eshleman, Chandrashekhar Voshavar, 2021, European journal of medicinal chemistry.

Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter

A. Abbas, A. Janowsky, A. Eshleman, 2023, The Journal of Pharmacology and Experimental Therapeutics.

Enantiomeric Separation, Absolute Configuration by X-ray Crystallographic Analysis, and Functional Evaluation of Enantiomers of the Dual Ligand, SYA0340 at 5-HT1A and 5-HT7A Receptors

A. Janowsky, Xinsong Lin, Chandrashekhar Voshavar, 2023, ACS omega.